未登录A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study一项多中心、随机、开放标签的2期研究，旨在探讨接受trastuzumab deruxtecan治疗的晚期/复发性胃癌患者的最佳止吐疗法：EN-hance研究
Aoyama, Toru; Ooki, Akira; Oba, Koji; Nishikawa, Kazuhiro; Kawabata, Ryohei; Honda, Michitaka; Maeda, Hiromichi; Kanda, Mitsuro; Sugiyama, Keiji; Makiyama, Akitaka; Segami, Kenki; Takahashi, Masazumi; Shindo, Yoshiaki; Namikawa, Tsutomu; Oshima, Takashi; Katayama, Aya; Shiosakai, Kazuhito; Sakamoto, Junichi .png)
分享.png)
收藏Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 studyShibahara, Hidetoshi; Shiroiwa, Takeru; Ishiguro, Megumi; Nakamura, Masato; Hasegawa, Junichi; Yamaguchi, Shigeki; Masuda, Yuriko; Sakamoto, Junichi; Tomita, Naohiro; Fukuda, Takashi 分享 收藏 Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 studyTomita, Naohiro; Kunieda, Katsuyuki; Maeda, Atsuyuki; Hamada, Chikuma; Yamanaka, Takeharu; Sato, Toshihiko; Yoshida, Kazuhiro; Boku, Narikazu; Nezu, Riichiro; Yamaguchi, Shigeki; Mishima, Hideyuki; Sadahiro, Sotaro; Muro, Kei; Ishiguro, Megumi; Sakamoto, Junichi; Saji, Shigetoyo; Maehara, Yoshihiko 分享 收藏 Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivativesNiida, Ayumu; Kanematsu-Yamaki, Yoko; Asakawa, Tomoko; Ishimura, Yoshimasa; Fujita, Hisashi; Matsumiya, Kouta; Nishizawa, Naoki; Adachi, Yusuke; Mochida, Taisuke; Tsuchimori, Kazue; Yoneyama-Hirozane, Mariko; Sakamoto, Junichi; Hirabayashi, Hideki; Fukui, Hideo; Takekawa, Shiro; Asami, Taiji 分享 收藏 Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug designYasui, Takeshi; Yamamoto, Takeshi; Sakai, Nozomu; Asano, Kouhei; Takai, Takafumi; Yoshitomi, Yayoi; Davis, Melinda; Takagi, Terufumi; Sakamoto, Kotaro; Sogabe, Satoshi; Kamada, Yusuke; Lane, Weston; Snell, Gyorgy; Iwata, Masashi; Goto, Masayuki; Inooka, Hiroshi; Sakamoto, Jun-ichi; Nakada, Yoshihisa; Imaeda, Yasuhiro 分享 收藏 Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multi-disciplinary Treatment of Cancer (JFMC) clinical trialsMaeda, Hiromichi; Kashiwabara, Kosuke; Aoyama, Toru; Oba, Koji; Honda, Michitaka; Mayanagi, Shuhei; Kanda, Mitsuro; Hamada, Chikuma; Sadahiro, Sotaro; Sakamoto, Junichi; Saji, Shigetoyo; Yoshikawa, Takaki 分享 收藏 Phase III trial of 24 weeks vs. 48 weeks capecitabine adjuvant chemotherapy for patients with stage III colon cancer: Final results of JFMC37-0801Yamaguchi, S.; Kunieda, K.; Sato, T.; Naramoto, Y.; Kobayashi, M.; Ogata, Y.; Furuhata, T.; Takii, Y.; Kusunoki, M.; Maehara, Y.; Koda, K.; Okuno, K.; Ohno, M.; Mishima, H.; Sadahiro, S.; Hamada, C.; Sakamoto, J.; Saji, S.; Tomita, N. 分享 收藏 Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial)Kanai, M.; Kawaguchi, T.; Kotaka, M.; Shinozaki, K.; Touyama, T.; Manaka, D.; Ishigure, K.; Hasegawa, J.; Munemoto, Y.; Matsui, T.; Takagane, A.; Ishikawa, H.; Matsumoto, S.; Sakamoto, J.; Saji, S.; Yoshino, T.; Ohtsu, A.; Watanabe, T.; Matsuda, F. 分享 收藏 Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trialImagawa, Jun; Tanaka, Hideo; Okada, Masaya; Nakamae, Hirohisa; Hino, Masayuki; Murai, Kazunori; Ishida, Yoji; Kumagai, Takashi; Sato, Seiichi; Ohashi, Kazuteru; Sakamaki, Hisashi; Wakita, Hisashi; Uoshima, Nobuhiko; Nakagawa, Yasunori; Minami, Yosuke; Ogasawara, Masahiro; Takeoka, Tomoharu; Akasaka, Hiroshi; Utsumi, Takahiko; Uike, Naokuni; Sato, Tsutomu; Ando, Sachiko; Usuki, Kensuke; Morita, Satoshi; Sakamoto, Junichi; Kimura, Shinya 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B两周一次的伊立替康用于先前治疗的HER2-negative转移性乳腺癌患者的II期研究: KMBOG0610BHayashi, Hidetoshi; Tsurutani, Junji; Satoh, Taro; Masuda, Norikazu; Okamoto, Wataru; Morinaga, Ryotaro; Terashima, Masaaki; Miyazaki, Masaki; Okamoto, Isamu; Nishida, Yukihiro; Tominaga, Shusei; Tokunaga, Yukihiko; Yamaguchi, Masahide; Sakamoto, Junichi; Nakayama, Takahiro; Nakagawa, Kazuhiko 分享 收藏 CRAFT Trial-Result From Multicenter Phase II Study of Modified FOLFOX7 (Combination Chemotherapy of Infusional 5-FU/I-Leucovorin and Intermittent Oxaliplatin) With Bevacizumab in the First-line Therapy of Colorectal CancerIshibashi, K.; Koda, K.; Oshiro, M.; Matsuoka, H.; Baba, H.; Ishida, H.; Katoh, R.; Maeda, K.; Hamada, C.; Sakamoto, J. 分享 收藏 Systematic syntheses of influenza neuraminidase inhibitors: A series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moietiesSakamoto, Jun-Ichi; Koyama, Tetsuo; Miyamoto, Daisei; Yingsakmongkon, Sangchai; Hidari, Kazuya I. P. J.; Jampangern, Wipawee; Suzuki, Takashi; Suzuki, Yasuo; Esumi, Yasuaki; Nakamura, Takemichi; Hatano, Ken; Terunuma, Daiyo; Matsuoka, Koji 分享 收藏 分享 收藏 An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancerSakamoto, J.; Hamada, C.; Yoshida, S.; Kodaira, S.; Yasutomi, M.; Kato, T.; Oba, K.; Nakazato, H.; Saji, S.; Ohashi, Y. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
